newsfilter
← Latest News
Earnings Call Transcripts·

Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call - OSCAR HEALTH INC

  • Financial Performance:

    • Q3 2026 revenue reached $5.1 billion, a 70% year-over-year increase driven by rate hikes and membership growth.
    • Q3 earnings from operations totaled $178 million ($307 million YoY improvement) with an operating margin of 3.5%; adjusted EBITDA was $207 million.
    • Full-year 2026 net income for the first nine months was $1.2 billion ($3.59 per diluted share); earnings from operations were $1.3 billion.
    • Medical Loss Ratio (MLR) improved 450 basis points YoY to 84% in Q3; full-year 2026 MLR guidance raised to 80.5%–81.5%.
    • SG&A expense ratio improved 350 basis points YoY to 14% in Q3 (historical low) due to AI efficiencies and fixed cost leverage.
    • Risk adjustment as a percentage of premiums was 11.8% in Q3 and 17.2% year-to-date; full-year guidance lowered to 17%–18% (previously ~20%).
    • Balance sheet held approximately $9 billion in cash investments; insurance subsidiaries reported $2.3 billion in capital surplus.
    • Received a $250 million revenue benefit from updated risk adjustment data reflecting favorable market morbidity relative to Oscar's book.
  • Guidance and Future Outlook:

    • Raised full-year 2026 earnings from operations guidance to $850 million–$950 million (previously $650 million–$750 million).
    • Full-year 2026 revenue guidance raised to $19 billion–$19.3 billion; expected year-end membership of 2.5 million.
    • Projected 2027 weighted average rate increase of approximately 14%, driven by high single-digit medical cost trends, higher market morbidity from program integrity, and margin expansion.
    • Expect 2027 ACA marketplace membership to be stable relative to year-end 2026, while targeting market share gains via new products and competitor exits.
    • Long-term goal remains at least $4.00 earnings per share by 2029; current performance suggests achieving 2024 Investor Day commitments one year ahead of schedule.
  • Business Segments and Product Lines:

    • Membership reached 2.7 million at end of Q3, up 27% YoY; footprint expanded to 713 counties including new entry into South Carolina.
    • Total addressable market expanded to ~10 million consumers across 21 states.
    • Launched "RetireEase" targeting 2.5 million early retirees with set prices for preventative and joint care; introduced bundled dental/vision benefits in hundreds of plans.
    • Partnership with Allstate Health Solutions provides low-cost supplemental coverage for Bronze members to manage out-of-pocket costs.
    • "Hy-Vee Health with Oscar" (concierge model for small business/gig workers) expanding to Nebraska, Missouri, and Kansas following success in Iowa.
    • "HelloMeno" launched off-exchange to serve women across the workforce.
    • "Lucy" AI platform projected to sell 800,000 policies in 2027, matching consumers with plans across major carriers.
  • Market and Competitive Landscape:

    • ACA marketplace viewed as a rapidly developing foundation for individual market growth driven by gig economy and career flexibility trends.
    • ~850,000 lives entering the market due to competitor exits, creating share acquisition opportunities.
    • Employer demand growing fastest in healthcare, technology, construction, and manufacturing sectors.
    • Pricing strategy balances disciplined rate increases with competitive positioning; not the lowest-cost option but competing on product quality and service.
    • Market morbidity trends remain moderately favorable to expectations despite Program Integrity initiatives removing non-utilizers from the risk pool.
  • Risks and Challenges:

    • CMS Program Integrity initiatives and enhanced eligibility reviews (including Social Security verification) leading to disenrollments and potential enrollment friction in Q4 and 2027.
    • Administrative complexity in synchronizing eligibility data between CMS and plans creates operational friction.
    • Elevated outpatient utilization, partly attributed to shifts from inpatient care due to affordability initiatives, though net cost impact remains favorable.
    • Uncertainty surrounding the 2028 policy landscape, specifically regarding auto-enrollment restrictions and potential changes to enhanced subsidies post-midterms.
    • Seasonal Q4 step-up in SG&A ratio due to open enrollment ramp-up, risk adjustment operations, and Q1 2027 growth investments.
  • Management Commentary and Tone:

    • Management expressed strong confidence in 2026 as the "strongest year in Oscar Health's history," citing record profitability and operational discipline.
    • Tone was optimistic and forward-looking, emphasizing AI-driven efficiencies, product innovation, and the ability to navigate regulatory changes.
    • CEO Mark Bertolini highlighted the strategic opportunity to expand the ACA into a competitive marketplace supporting a resilient economy.
    • CFO Scott Blackley noted the company is "walking into good news" while maintaining a prudent stance on morbidity risks.
  • Analyst Questions and Answers:

    • SG&A Drivers: Strong Q3 SG&A performance attributed to AI deployment and fixed cost leverage; Q4 step-up is seasonal due to risk adjustment chart collection and OE ramp.
    • Market Share: Share gains expected to come from new geographic expansions, niche products (RetireEase), and displacing competitors exiting the market.
    • Utilization/Metal Mix: No specific utilization anomalies by metal tier; outpatient elevation linked to affordability initiatives and care rotation; MLR expected to rise seasonally in Q4.
    • Policy/Midterms: Management anticipates 2027 membership stability despite Program Integrity; 2028 policy changes (subsidies, auto-enrollment) remain uncertain and subject to legislative negotiations.
    • Pricing Breakdown: 14% rate increase composed of high single-digit trends, market morbidity impacts, and a component for margin enhancement.
    • Risk Adjustment: 2026 risk adjustment ratio of 17-18% is book-specific; next year's ratio will depend on 2027 membership mix.
  • Other Key Points:

    • Disenrollments from CMS eligibility reviews were in line with expectations, with a smaller second review expected to cause minimal additional Q4 churn.
    • Allstate partnership and Hy-Vee expansion demonstrate success in targeting underserved segments like Bronze members and gig workers.
    • Technology platform "Lucy" is central to distribution strategy, enabling brokers to navigate complex eligibility rules efficiently.
    • Oscar supports Program Integrity as a means to stabilize the risk pool, despite acknowledging the operational complexity of dispersed eligibility responsibilities.
Company
OSCAR HEALTH INC
Keywords
OSCAR HEALTH INC